PENTAMUSTINE

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C8H16ClN3O2
Molecular Weight	221.685
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC(C)(C)CNC(=O)N(CCCl)N=O

InChI

InChIKey=UOAFGUOASVSLPK-UHFFFAOYSA-N

InChI=1S/C8H16ClN3O2/c1-8(2,3)6-10-7(13)12(11-14)5-4-9/h4-6H2,1-3H3,(H,10,13)

HIDE SMILES / InChI

Description

Pentamustine is an alkylating agent that was developed for the treatment of cancer. However, information about the further development of this compound is not available.

Approval Year

PubMed

Show entries

Title	Date	PubMed
Role of uteroglobin and transglutaminase in masking the antigenicity of implanting rabbit embryos.	1982 Jun	6126131

Showing 1 to 1 of 1 entries

Previous1Next

Patents

Show entries

Name

Type

Language

PENTAMUSTINE

Official Name

English

NEPTAMUSTINE

Official Name

English

UREA, N-(2-CHLOROETHYL)-N'-(2,2-DIMETHYLPROPYL)-N-NITROSO-

Systematic Name

English

SALISBURYSTIN

Brand Name

English

neptamustine [INN]

Common Name

English

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Classification Tree

Code System

Code

Antineoplastic Alkylating Agent

NCI_THESAURUS

C699

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

EVMPD

SUB09201MIG

PRIMARY

NCI_THESAURUS

C66341

PRIMARY

FDA UNII

VB67O9FBGM

PRIMARY

ChEMBL

CHEMBL462222

PRIMARY

EPA CompTox

DTXSID70223380

PRIMARY

Showing 1 to 5 of 9 entries

Previous1 2Next

ACTIVE MOIETY


					VB67O9FBGM

PENTAMUSTINE